-
1
-
-
0021929962
-
Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta
-
Maruyama I., Bell C.E., Majerus P.W. Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta. J Cell Biol. 101:1985;363-371.
-
(1985)
J Cell Biol
, vol.101
, pp. 363-371
-
-
Maruyama, I.1
Bell, C.E.2
Majerus, P.W.3
-
2
-
-
0000650903
-
Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C
-
Esmon C.T., Owen W.G. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA. 78:1981;2249-2252.
-
(1981)
Proc Natl Acad Sci USA
, vol.78
, pp. 2249-2252
-
-
Esmon, C.T.1
Owen, W.G.2
-
3
-
-
0020063793
-
Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C
-
Esmon N.L., Owen W.G., Esmon C.T. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem. 257:1982;859-864.
-
(1982)
J Biol Chem
, vol.257
, pp. 859-864
-
-
Esmon, N.L.1
Owen, W.G.2
Esmon, C.T.3
-
4
-
-
0024558370
-
The roles of protein C and thrombomodulin in the regulation of blood coagulation
-
Esmon C.T. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem. 264:1989;4736-4743.
-
(1989)
J Biol Chem
, vol.264
, pp. 4736-4743
-
-
Esmon, C.T.1
-
5
-
-
0025174705
-
Structure and function of thrombomodulin: A natural anticoagulant
-
Dittman W.A., Majerus P.W. Structure and function of thrombomodulin: A natural anticoagulant. Blood. 75:1990;329-336.
-
(1990)
Blood
, vol.75
, pp. 329-336
-
-
Dittman, W.A.1
Majerus, P.W.2
-
6
-
-
0022396035
-
Thrombomodulin is present in human plasma and urine
-
Ishii H., Majerus P.W. Thrombomodulin is present in human plasma and urine. J Clin Invest. 76:1985;2178-2181.
-
(1985)
J Clin Invest
, vol.76
, pp. 2178-2181
-
-
Ishii, H.1
Majerus, P.W.2
-
7
-
-
0025896578
-
Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells
-
Ishii H., Uchiyama H., Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost. 65:1991;618-623.
-
(1991)
Thromb Haemost
, vol.65
, pp. 618-623
-
-
Ishii, H.1
Uchiyama, H.2
Kazama, M.3
-
8
-
-
0025241217
-
Plasma thrombomodulin in health and diseases
-
Takano S., Kimura S., Ohdama S., Aoki N. Plasma thrombomodulin in health and diseases. Blood. 76:1990;2024-2029.
-
(1990)
Blood
, vol.76
, pp. 2024-2029
-
-
Takano, S.1
Kimura, S.2
Ohdama, S.3
Aoki, N.4
-
9
-
-
0025936804
-
Circulating thrombomodulin in thrombotic thrombocytopenic purpura
-
Takahashi H., Hanano K., Wada K., et al. Circulating thrombomodulin in thrombotic thrombocytopenic purpura. Am J Hematol. 38:1991;174-177.
-
(1991)
Am J Hematol
, vol.38
, pp. 174-177
-
-
Takahashi, H.1
Hanano, K.2
Wada, K.3
-
10
-
-
0025945404
-
Serum thrombomodulin and anticardiolipin antibodies in patients with systemic lupus erythematosus
-
Takaya M., Ichikawa Y., Kobayashi N., et al. Serum thrombomodulin and anticardiolipin antibodies in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 9:1991;495-499.
-
(1991)
Clin Exp Rheumatol
, vol.9
, pp. 495-499
-
-
Takaya, M.1
Ichikawa, Y.2
Kobayashi, N.3
-
11
-
-
0025371576
-
Elevation of plasma thrombomodulin concentration in diabetic patients with early diabetic nephropathy
-
Iwashima Y., Sato T., Watanabe K., et al. Elevation of plasma thrombomodulin concentration in diabetic patients with early diabetic nephropathy. Diabetes. 39:1990;983-988.
-
(1990)
Diabetes
, vol.39
, pp. 983-988
-
-
Iwashima, Y.1
Sato, T.2
Watanabe, K.3
-
12
-
-
0025819299
-
Increased thrombomodulin values in plasma of diabetic men with microangiopathy
-
Tanaka A., Ishii H., Hiraishi S., Kazama M., Maezawa H. Increased thrombomodulin values in plasma of diabetic men with microangiopathy. Clin Chem. 37:1991;269-272.
-
(1991)
Clin Chem
, vol.37
, pp. 269-272
-
-
Tanaka, A.1
Ishii, H.2
Hiraishi, S.3
Kazama, M.4
Maezawa, H.5
-
13
-
-
0028243832
-
Elevated serum and urinary thrombomodulin concentrations in patients with non-insulin-dependent diabetes mellitus
-
Shimano H., Takahashi K., Kawakami M., et al. Elevated serum and urinary thrombomodulin concentrations in patients with non-insulin-dependent diabetes mellitus. Clin Chim Acta. 225:1994;89-96.
-
(1994)
Clin Chim Acta
, vol.225
, pp. 89-96
-
-
Shimano, H.1
Takahashi, K.2
Kawakami, M.3
-
14
-
-
0030198368
-
Clinical significance of measurements of urinary and serum thrombomodulin in patients with non-insulin-dependent diabetes mellitus
-
Inukai T., Fujiwara Y., Tayama K., Aso Y., Takemura Y. Clinical significance of measurements of urinary and serum thrombomodulin in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract. 33:1996;99-104.
-
(1996)
Diabetes Res Clin Pract
, vol.33
, pp. 99-104
-
-
Inukai, T.1
Fujiwara, Y.2
Tayama, K.3
Aso, Y.4
Takemura, Y.5
-
15
-
-
0031886870
-
Mechanisms of elevation of serum and urinary thrombomodulin in diabetic patients: Possible application as a marker for vascular endothelial injury
-
Aso Y., Inukai T., Takemura Y. Mechanisms of elevation of serum and urinary thrombomodulin in diabetic patients: possible application as a marker for vascular endothelial injury. Metabolism. 47:1998;362-365.
-
(1998)
Metabolism
, vol.47
, pp. 362-365
-
-
Aso, Y.1
Inukai, T.2
Takemura, Y.3
-
16
-
-
0029060078
-
Soluble thrombomodulin purified from human urine exhibits a potent anticoagulant effect in vitro and in vivo
-
Takahashi Y., Hosaka Y., Niina H., et al. Soluble thrombomodulin purified from human urine exhibits a potent anticoagulant effect in vitro and in vivo. Thromb Haemost. 73:1995;805-811.
-
(1995)
Thromb Haemost
, vol.73
, pp. 805-811
-
-
Takahashi, Y.1
Hosaka, Y.2
Niina, H.3
-
17
-
-
0031935464
-
Thrombomodulin in human plasma contributes to inhibit fibrinolysis through acceleration of thrombin-dependent activation of plasma procarboxypeptidase B
-
Hosaka Y., Takahashi Y., Ishii H. Thrombomodulin in human plasma contributes to inhibit fibrinolysis through acceleration of thrombin-dependent activation of plasma procarboxypeptidase B. Thromb Haemost. 79:1998;371-377.
-
(1998)
Thromb Haemost
, vol.79
, pp. 371-377
-
-
Hosaka, Y.1
Takahashi, Y.2
Ishii, H.3
-
18
-
-
0025214642
-
Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies
-
Ishii H., Nakano M., Tsubouchi J., et al. Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies. Thromb Haemost. 63:1990;157-162.
-
(1990)
Thromb Haemost
, vol.63
, pp. 157-162
-
-
Ishii, H.1
Nakano, M.2
Tsubouchi, J.3
-
19
-
-
0023191754
-
Protein C: Comparison of different assay in normal and abnormal plasma samples
-
Vinazzer H., Pangraz U. Protein C: comparison of different assay in normal and abnormal plasma samples. Thromb Res. 46:1987;1-8.
-
(1987)
Thromb Res
, vol.46
, pp. 1-8
-
-
Vinazzer, H.1
Pangraz, U.2
-
20
-
-
10544228517
-
Protein C activation in NIDDM patients
-
Gabazza E.C., Takeya H., Deguchi H., et al. Protein C activation in NIDDM patients. Diabetologia. 39:1996;1455-1461.
-
(1996)
Diabetologia
, vol.39
, pp. 1455-1461
-
-
Gabazza, E.C.1
Takeya, H.2
Deguchi, H.3
-
21
-
-
0032879262
-
Endothelial cell dysfunction and the pathogenesis of diabetic macroangiopathy
-
Laight D.W., Carrier M.J., Änggård E.E. Endothelial cell dysfunction and the pathogenesis of diabetic macroangiopathy. Diabetes Metab Res Rev. 15:1999;274-282.
-
(1999)
Diabetes Metab Res Rev
, vol.15
, pp. 274-282
-
-
Laight, D.W.1
Carrier, M.J.2
Änggård, E.E.3
-
22
-
-
0034640107
-
Vascular superoxide production by NAD(P)H oxidase: Association with endothelial dysfunction and clinical risk factors
-
Guzik T.J., West N.E., Black E., McDonald D., Ratnatunga C., Pillai R., Channon K.M. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res. 86:2000;E85-90.
-
(2000)
Circ Res
, vol.86
, pp. 85-90
-
-
Guzik, T.J.1
West, N.E.2
Black, E.3
McDonald, D.4
Ratnatunga, C.5
Pillai, R.6
Channon, K.M.7
-
23
-
-
0344286498
-
Activation of receptor for advanced glycation end products: A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis
-
Schmidt A.M., Yan S.D., Wautier J.-L., Stern D. Activation of receptor for advanced glycation end products: A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res. 84:1999;489-497.
-
(1999)
Circ Res
, vol.84
, pp. 489-497
-
-
Schmidt, A.M.1
Yan, S.D.2
Wautier, J.-L.3
Stern, D.4
-
24
-
-
0031765785
-
Effects of recombinant human soluble thrombomodulin (rhs-TM) on clot-induced coagulation in human plasma
-
Mohri M., Suzuki M., Sugimoto E., Sata M., Yamamoto S. Effects of recombinant human soluble thrombomodulin (rhs-TM) on clot-induced coagulation in human plasma. Thromb Haemost. 80:1998;925-929.
-
(1998)
Thromb Haemost
, vol.80
, pp. 925-929
-
-
Mohri, M.1
Suzuki, M.2
Sugimoto, E.3
Sata, M.4
Yamamoto, S.5
-
25
-
-
0030984689
-
Elevated serum concentrations and reduced immunohistochemical expression of thrombomodulin in acute ulcerative colitis
-
Behme M.W.J., Autschbach F., Zuna I., et al. Elevated serum concentrations and reduced immunohistochemical expression of thrombomodulin in acute ulcerative colitis. Gastroenterology. 113:1997;107-117.
-
(1997)
Gastroenterology
, vol.113
, pp. 107-117
-
-
Behme, M.W.J.1
Autschbach, F.2
Zuna, I.3
-
27
-
-
0000157118
-
Vascular thrombosis in diabetes
-
D. Jr. Porte, & R.S. Sherwin. Stamford: Appleton and Lange
-
Colwell J.A., Jokl R. Vascular thrombosis in diabetes. Porte D. Jr., Sherwin R.S. Ellenberg and Rifkin’s diabetes mellitus. 5th ed:1997;207-216 Appleton and Lange, Stamford.
-
(1997)
Ellenberg and Rifkin’s Diabetes Mellitus 5th Ed
, pp. 207-216
-
-
Colwell, J.A.1
Jokl, R.2
-
28
-
-
11944265051
-
Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes
-
Ganda O.P., Arkin C.F. Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes. Diabetes Care. 15:1992;1245-1250.
-
(1992)
Diabetes Care
, vol.15
, pp. 1245-1250
-
-
Ganda, O.P.1
Arkin, C.F.2
-
29
-
-
0028009948
-
Fibrinogen plasma concentrations as a marker of thrombin activation in diabetes
-
Ceriello A., Taboga C., Giacomello R., et al. Fibrinogen plasma concentrations as a marker of thrombin activation in diabetes. Diabetes. 43:1994;430-432.
-
(1994)
Diabetes
, vol.43
, pp. 430-432
-
-
Ceriello, A.1
Taboga, C.2
Giacomello, R.3
-
30
-
-
0032912811
-
Diabetes and cardiovascular disease
-
Sower J.R., Lester M.A. Diabetes and cardiovascular disease. Diabetes Care. 22:1999;C14-C20.
-
(1999)
Diabetes Care
, vol.22
, pp. 14-C20
-
-
Sower, J.R.1
Lester, M.A.2
-
31
-
-
0028815556
-
Plasma carboxypeptidases as regulators of the plasminogen system
-
Redlitz A., Tan A.K., Plow E.F. Plasma carboxypeptidases as regulators of the plasminogen system. J Clin Invest. 96:1995;2534-2538.
-
(1995)
J Clin Invest
, vol.96
, pp. 2534-2538
-
-
Redlitz, A.1
Tan, A.K.2
Plow, E.F.3
-
32
-
-
0029895009
-
TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through thrombin-thrombomodulin complex
-
Bajzar L., Morser J., Nesheim M. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through thrombin-thrombomodulin complex. J Biol Chem. 271:1996;16603-16608.
-
(1996)
J Biol Chem
, vol.271
, pp. 16603-16608
-
-
Bajzar, L.1
Morser, J.2
Nesheim, M.3
-
33
-
-
0343620069
-
New concepts about pathogenesis of atherosclerosis and thrombosis in diabetes mellitus
-
M.E. Levin, L.W. O’Neal, & J.H. Bowker. St. Louis: Mosby
-
Colwell J.A., Lyons T.J., Klein R.L., Lopes-Virella M.F. New concepts about pathogenesis of atherosclerosis and thrombosis in diabetes mellitus. Levin M.E., O’Neal L.W., Bowker J.H. The diabetic foot. 5th ed:1993;79-114 Mosby, St. Louis.
-
(1993)
The Diabetic Foot 5th Ed
, pp. 79-114
-
-
Colwell, J.A.1
Lyons, T.J.2
Klein, R.L.3
Lopes-Virella, M.F.4
-
34
-
-
0030874906
-
Hyperinsulinemia and hypofibrinolysis: Effects of short-term optimized glycemic control with continuous insulin infusion in type II diabetic patients
-
Lomeau B., Aurousseau M.H., Valensi P., Paries J., Attali J.R. Hyperinsulinemia and hypofibrinolysis: effects of short-term optimized glycemic control with continuous insulin infusion in type II diabetic patients. Metabolism. 46:1997;1074-1079.
-
(1997)
Metabolism
, vol.46
, pp. 1074-1079
-
-
Lomeau, B.1
Aurousseau, M.H.2
Valensi, P.3
Paries, J.4
Attali, J.R.5
-
35
-
-
0027241856
-
The pathogenesis of atherosclerosis; A perspective for 1990s
-
Ross R. The pathogenesis of atherosclerosis; a perspective for 1990s. Nature. 362:1993;801-809.
-
(1993)
Nature
, vol.362
, pp. 801-809
-
-
Ross, R.1
-
36
-
-
0033552883
-
Atherosclerosis- an inflammatory disease
-
Ross R. Atherosclerosis- an inflammatory disease. N Engl J Med. 340:1999;115-126.
-
(1999)
N Engl J Med
, vol.340
, pp. 115-126
-
-
Ross, R.1
-
37
-
-
0033594760
-
Soluble thrombomodulin as a predictor coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) study: A case-cohort study
-
Salomaa V., Matei C., Aleksic N., Sansores-Garcia L., Folsom A.R., Juneja H., Chambless L.E., Wu K.K. Soluble thrombomodulin as a predictor coronary heart disease and symptomless carotid artery atherosclerosis in the Atherosclerosis Risk in Communities (ARIC) study: a case-cohort study. Lancet. 353:1999;1729-1734.
-
(1999)
Lancet
, vol.353
, pp. 1729-1734
-
-
Salomaa, V.1
Matei, C.2
Aleksic, N.3
Sansores-Garcia, L.4
Folsom, A.R.5
Juneja, H.6
Chambless, L.E.7
Wu, K.K.8
|